癌症負擔研究

Cancer related Consumption burden

10.6338/JDA.201804_13(2).0004

謝邦昌(Ben-Chang Shia)；林恆慶(Herng-Ching Lin)；陳正怡(Chang-I Chen)；丁台怡(Tai-I Ting)

癌症負擔 ； 癌症治療 ； 癌症費用 ； 免疫療法 ； Cancer burden ； cancer treatment ； cancer costs ； immunotherapy

Journal of Data Analysis

13卷2期（2018 / 04 / 01）

63 - 76

繁體中文

為瞭解國內癌症負擔及需求，本研究分別以文獻探討、健保資料庫分析及抽樣調查來深入探討醫藥支付方、患者、照護人員挖掘尚未被滿足的醫療需求，了解目前國內癌症護理和治療的資源之合理性及充分性。在420位受訪者中，有51.4%的受訪者對治療此疾病曾有經濟方面的問題。每個月平均需自費13,920元醫療及照護費用(含照護、止吐針等費用)，有將近六成的病患認為應增加全民健保所提供的癌症醫療給付，有三成的病患認為應把免疫療法列入給付項目。病患在台灣由罹癌到失能至死亡，中間一段失能時間太長，都是導致家屬政府經濟負擔的原因。應縮短施能時間，減少家庭與國家負擔。癌症治療的存活率進步不可能不需要經費，這一部份需要進步也需要經費投入治療端與研發端。

The population structure of Taiwan is aging gradually, the death rate of cancer is increasing every year, the cancer medical expense continues to rise, and the quality of life of the patients and the family also causes huge social burden. Therefore, we use the citation analysis and sample survey to compare the direct medical costs and indirect medical expenses of cancer care in Taiwan and international. Includes comparative social burden differences and survival rates for lung cancer, hepatoma, head and neck cancer, malignant melanoma, renal cell carcinoma, gastric cancer, and bladder cancer by disability adjusted life years(DALYs). The survival rate of cancer, gastric cancer, bladder cancer and other cancers is compared to understand the current situation in Taiwan such as cancer survival rate, cancer care and treatment cost burden, medical care needs, and registration time of new medicines, etc., to provide relevant cancers. Of the 420 respondents, 51.4% had economic problems with the treatment of this disease. On average, there is a monthly fee of 13,920 yuan for medical treatment and care (including care and anti-sputum needles). Nearly 60% of the patients think that they should increase the amount of cancer medical care provided by the National Health Insurance, and 30% of the patients think that they should Immunotherapy is included in the payment program. To sum up, the health policy of our country should focus on how to reduce the social burden, how to improve the cure rate of cancer, and establish a perfect medical cost subsidy mechanism and new drug research.

1. 葉玲瓏、高翊瑋、李天行、陳銘芷(2015)。資料庫加值之資料整合應用：以台北老人健保及健檢資料為例。數據分析，10(1)，17-28。
   連結：
2. Allemani, C.,Weir, H. K.,Carreira, H.,Harewood, R.,Spika, D.,Wang, X. S.,Coleman, M. P.(2015).Global surveillance of cancer survival 1995-2009: analysis of individual data for25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).Lancet,385(9972),977-1010.
3. Berry, M.J.A.,Linoff, G.S.(1997).Data Mining Techniques: for Marketing, Sales, and Customer Support.New York:John Wiley & Sons Inc.
4. Berry, Michael J. A.,Linoff, G. S.(2000).Mastering data mining : the art and science of customer relationship management.New York:Wiley Computer Pub.
5. Brenner, H.,Hakulinen, T.(2003).On crude and age-adjusted relative survival rates.J Clin Epidemiol,56(12),1185-1191.
6. Brenner, H.,Hakulinen, T.(2006).Up-to-date estimates of cancer patient survival even with common latency in cancer registration.Cancer Epidemiol Biomarkers Prev,15(9),1727-1732.
7. Chang, H. Y.,Feng, H. L.,Wang, L.,Chou, P.,Wang, P. F.(2014).The Incidence, Prevalence, and Survival of Malignant Melanoma in Taiwan.Value Health,17(7),A740.
8. Chapman, P.,Clinton, J.,Kerber, R.,Khabaza, T.,Reinartz, T.,Shearer, C.,Wirth, R.(2000).CRISP-DM1.0 Step-by-step data mining guide.CRISP-DM Consortium
9. Chiang, C. J.,Lo, W. C.,Yang, Y. W.,You, S. L.,Chen, C. J.,Lai, M. S.(2016).Incidence and survival of adult cancer patients in Taiwan, 2016,pp.2002-2012.J Formos Med Assoc,115(12),1076-1088.
10. Chiu, H. F.,Kuo, C. C.,Kuo, H. W.,Lee, I. M.,Yang, C. Y.(2014).Parity, age at first birth and risk of death from kidney cancer: a population-based cohort study in Taiwan.Eur J Public Health,24(2),249-252.
11. de Oliveira, C.,Bremner, K. E.,Pataky, R.,Gunraj, N.,Chan, K.,Peacock, S.,Krahn, M. D.(2013).Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study.CMAJ open,1(1),E1-E8.
12. de Oliveira, C.,Pataky, R.,Bremner, K. E.,Rangrej, J.,Chan, K. K.,Cheung, W. Y.,Krahn, M. D.(2016).Phase-specific and lifetime costs of cancer care in Ontario, Canada.BMC cancer,16(1),809.
13. Eberle, A.,Jansen, L.,Castro, F.,Krilaviciute, A.,Luttmann, S.,Emrich, K.,Brenner, H.(2015).Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients.Lung Cancer,90(3),528-533.
14. Freeman, J.A.,Skapura, D.M.(1992).Neural networks: algorithms, applications and programming techniques.Reading, Massachusetts:USA, Addison-Wesley Publishing Company.
15. Friedman, J.(1991).Multivariate adaptive regression splines (with discussion).Annals of Statistics,19,1-141.
16. Glymour, C.,Madigan, D.,Pregibon, D.,Smyth, P.(1996).Statistical inference and data mining.Communications of the ACM,39(11),35-41.
17. Glymour, C.,Madigan, D.,Pregibon, D.,Smyth, P.(1996).Statistical themes and lessons for data mining.Annals of Statistics,1,35-41.
18. Gondos, A.,Bray, F.,Hakulinen, T.,Brenner, H.(2009).Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis.Annals of Oncology,20(3),564-573.
19. Gong, Y.,Yoon, S. J.,Jo, M. W.,Kim, A.,Kim, Y. A.,Yoon, J.,Kim, D.(2016).The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach.J Korean Med Sci,31(Suppl 2),S168-177.
20. Han, J.,Kamber, M.(2001).Data Mining: Concepts and Techniques.CA:Morgan Kaufmann Publisher.
21. Hastie, T.,Tibshirani, R.,Friedman, J.(2001).The elements of statistical learning: data mining, inference, and prediction.NY:Springer-Verlag.
22. Jansen, L.,Castro, F. A.,Gondos, A.,Krilaviciute, A.,Barnes, B.,Eberle, A.,Brenner, H.(2015).Recent cancer survival in Germany: an analysis of common and less common cancers.Int J Cancer,136(11),2649-2658.
23. Jung, K. W.,Won, Y. J.,Oh, C. M.,Kong, H. J.,Lee, D. H.,Lee, K. H.(2017).Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014.Cancer Res Treat,49(2),292-305.
24. Kitazawa, T.,Matsumoto, K.,Fujita, S.,Seto, K.,Hanaoka, S.,Hasegawa, T.(2015).Cost of illness of the prostate cancer in Japan—a time-trend analysis and future projections.BMC health services research,15(1),453.
25. Laudicella, M.,Walsh, B.,Burns, E.,Smith, P. C.(2016).Cost of care for cancer patients in England: evidence from population-based patient-level data.British journal of cancer,114(11),1286-1292.
26. Lee, Kwang-Sig(2015).Economic Burden of Cancer in Korea during 2000-2010.Cancer Res Treat,47(3),387-398.
27. Lepage, C.,Capocaccia, R.,Hackl, M.,Lemmens, V.,Molina, E.,Pierannunzio, D.,Faivre, J.(2015).Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.Eur J Cancer
28. Li, T. Y.,Hsieh, J. S.,Lee, K. T.,Hou, M. F.,Wu, C. L.,Kao, H. Y.,Shi, H. Y.(2014).Cost trend analysis of initial cancer treatment in Taiwan.PLoS One,9(10),e108432.
29. Luengo-Fernandez, R.,Leal, J.,Gray, A.,Sullivan, R.(2013).Economic burden of cancer across the European Union: a population-based cost analysis.The lancet oncology,14(12),1165-1174.
30. MacQueen, J. B.(1967).Some methods for classification and analysis of multivariate observations.Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability
31. Mariotto, A. B.,Yabroff, K. R.,Shao, Y.,Feuer, E. J.,Brown, M. L.(2011).Projections of the cost of cancer care in the United States: 2010-2020.J Natl Cancer Inst,103(2),117-128.
32. OECD,Eurostat(2005).OSLO Manual: Guidelines for Collecting and Interpreting Innovation Data.OECD publishing.
33. Ohnuki, K.,Kuriyama, S.,Shoji, N.,Nishino, Y.,Tsuji, I.,Ohuchi, N.(2006).Cost‐effectiveness analysis of screening modalities for breast cancer in Japan with special reference to women aged 40-49 years.Cancer science,97(11),1242-1247.
34. Okamoto, N.(2000).Cost‐effectiveness of lung cancer screening in Japan.Cancer,89(S11),2489-2493.
35. Ott, R. L.(1993).An introduction to statistical methods and data analysis.Belmont, Calif.:Duxbury Press.
36. Pendrith, C.,Thind, A.,Zaric, G. S.,Sarma, S.(2016).Costs of cervical cancer treatment: population-based estimates from Ontario.Current Oncology,23(2),e109.
37. Pyle, D.(1999).Data preparation for data mining.San Francisco:Morgan Kaufmann Publishers.
38. Quaresma, M.,Coleman, M. P.,Rachet, B.(2015).40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England andWales,1971-2011: a population-based study.Lancet,385(9974),1206-1218.
39. Sankaranarayanan, R.,Swaminathan, R.,Brenner, H.,Chen, K.,Chia, K. S.,Chen, J. G.,Al-Hamdan, N.(2010).Cancer survival in Africa, Asia, and Central America: a population-based study.Lancet Oncol,11(2),165-173.
40. Scheaffer, R. L.,Mendenhall, W.,Ott R. L.(1996).Elementary Survey Sampling.Wadsworth Publishing Company.
41. Shin, J. Y.,Kim, S. Y.,Lee, K. S.,Lee, S. I.,Ko, Y.,Choi, Y. S.,Park, J. H.(2012).Costs during the first five years following cancer diagnosis in Korea.Asian Pac J Cancer Prev,13(8),3767-3772.
42. Tenopir, C.(1990).Value-Added Searching.Library Journal,115(6),79.
43. Vellido, A.,Lisboa, P. J. G.,Vaughan, J.(1999).Neural Networks in Business: A Survey of Applications.Expert Systems with Applications,17(1),51-70.
44. Westphal, C.,Blaxton, T.(1998).Data mining solutions: methods and tools for solving real-world problem.
45. Witten, I. H.,Frank, E.(1999).Data Mining: practical machine learning tools and techniques with Java implementations.CA:Morgan Kaufmann Publishers.
46. 行政院衛生福利部健康署(2017)。民國103 年國民醫療保健支出統計表
47. 行政院衛生福利部健康署(2016)。行政院衛生福利部健康署(2016)。中華民國102 年癌症登記報告。
48. 高翊瑋(2014)。碩士論文(碩士論文)。輔仁大學統計資訊學系應用統計碩士班。
49. 趙皓恩(2013)。碩士論文(碩士論文)。輔仁大學統計資訊學系應用統計碩士班。
50. 謝邦昌(2001)。資料採礦入門及應用～從統計技術看資料採礦。台北:資商訊息顧問股份有限公司。
51. 謝邦昌(2015)。Text Mining 文本探勘。台北:中華資料採礦協會。

1. 方俊凱(2023)。癌症病人的心理需求專業服務要健保給付還是患者自費。諮商與輔導，451，40-41。